drugset / Trial / NCT05470855
Protective Effect, Safety and Immunogenicity of Live Attenuated Varicella Vaccine in Anhui Province
Non-randomizedParallel-groupOpen-labelPrevention
Summary
This is Phase 4 clinical trial of live attenuated varicella vaccines manufactured by Sinovac (Dalian) Vaccine Technology Co., Ltd .The purpose of this study is to evaluate the protective effect of varicella vaccine in children aged 1-12 years and the correlation between varicella antibody and protective effect,to evaluate the immunogenicity and safety of varicella vaccine in children aged 1-12 years.
Timeline
- Start
- 2022-07-06
- Primary completion
- 2022-11-30
- Completion
- 2023-02-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Live Attenuated Varicella Vaccine | Vaccine | 0.5 ml | Intramuscular |